Feature Reports

The prescription drug market still runs through three gatekeepers-CVS Caremark (NYSE: CVS), Cigna’s Express Scripts (NYSE: CI), and UnitedHealth’s OptumRx (NYSE: UNH)-but the regulatory vise has squeezed out their most profitable practices. The stocks have already taken a beating but might go lower unless they take action now. This disruption in the market creates an… Continue reading PBM’s Under Regulatory Attack-Blockchain Upstart WGRX Belongs on Investor’s Radar

Global infrastructure spending is accelerating. Governments and enterprises are committing record capital to transportation, energy, utilities, telecom, and public works. The challenge is execution. Surveying, inspecting, documenting, and maintaining assets is hitting its limits. Labor shortages, rising insurance costs, and stricter compliance rules make traditional fieldwork expensive and slow. That gap is fueling demand for… Continue reading ZenaTech Inc. (Nasdaq: ZENA): Leveraging Drones to Solve Labor Constraints in Infrastructure

Global infrastructure and agricultural markets face unprecedented pressure for speed, precision, and automation. The World Bank estimates global infrastructure investment needs will exceed $16 trillion by 2030, while the FAO projects food production must grow 50% over the next decade to meet rising demand. Traditional surveying, ground inspections, and manual monitoring increasingly fail to keep… Continue reading ZenaTech, Inc. (NASDAQ: ZENA): Integrating Drones and DaaS to Address Growing Infrastructure and Agriculture Needs

Retail participation is quietly rebuilding momentum in early 2026. Trading activity across equities and digital assets is increasing, speculative interest is returning, and investor attention is spreading across more platforms, newsletters, and social channels than ever before. Yet while participation is rising, signal quality remains uneven. Investors face more data, more commentary, and more noise,… Continue reading Aether Holdings, Inc. (NASDAQ: ATHR): Turning Investor Attention Into Actionable Signals

Global markets are entering 2026 amid mixed macroeconomic signals, shifting investor sentiment, and continued debate around inflation, labor strength, and geopolitical risk. As information velocity increases and market narratives turn more quickly, investors are placing greater emphasis on how data is interpreted rather than simply how much data is available. At the same time, advances… Continue reading Aether Holdings, Inc. (NASDAQ: ATHR) Is Building the AI-Fueled Investor Toolbox

Modern defense strategy is being reshaped by a simple reality: situational awareness wins conflicts. From border security to logistics, reconnaissance, and infrastructure protection, governments increasingly prioritize technologies that deliver persistent, real-time intelligence without placing personnel in harm’s way. Drones have moved from experimental tools to foundational defense infrastructure, and recent U.S. policy actions are accelerating… Continue reading ZenaTech (NASDAQ: ZENA): From Flight Trials to Full-Scale National Security Platforms

The global Drone-as-a-Service (DaaS) market is booming, valued at $9.42 billion in 2022 and projected to grow at a 36.6% CAGR through 2034. Businesses in solar energy, agriculture, telecom, construction, and defense are adopting drones for surveying, inspection, monitoring, and maintenance, recognizing drones deliver data faster, safer, and more cost-effectively than traditional methods. In solar… Continue reading ZenaTech (NASDAQ: ZENA): Turning Drones into High-Growth, Recurring Services for Industrial Infrastructure

As 2025 draws to a close, U.S. equity markets are once again grappling with a familiar tension. Investors are trying to price in the possibility of future interest rate cuts while simultaneously navigating sharp sector rotations, crowded positioning, and growing dispersion beneath headline index performance. While major benchmarks have held up, leadership has shifted repeatedly,… Continue reading Heading Into Year-End, Aether Holdings (ATHR) Poised to Redefine Investor Intelligence

The biggest constraint on artificial intelligence expansion today is no longer the supply of semiconductors. It is power. AI data centers demand enormous, uninterrupted electricity at scales most grids were never designed to handle. As workloads accelerate worldwide, governments, sovereign investors, and infrastructure operators are confronting a hard truth: without reliable, scalable baseload energy, AI… Continue reading AI’s Power Bottleneck Is Shaping Two Public-Market Setups: Trump Media & Technology Group (NASDAQ: DJT) and VivoPower International PLC (NASDAQ: VVPR)

Actinium Pharmaceuticals (NYSE American: ATNM) is advancing its Trop-2–targeted ATNM-400 construct into Phase 1/2 trials across the United States and Australia, marking an important step as the company broadens its presence in solid-tumor radiopharmaceuticals. With targeted alpha radiotherapy gaining momentum worldwide, the program reinforces Actinium’s position as one of the more established players developing actinium-225–based… Continue reading Actinium Pharmaceuticals Advances Trop-2 Targeted Alpha Radiotherapy Into Phase 1/2 Trials in the U.S. and Australia